Morgan Stanley Call 16 DVAX 20.09.../ DE000ME9SKA1 /
19/08/2024 20:51:23 | Chg.- | Bid22:00:34 | Ask22:00:34 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.230EUR | - | - Bid Size: - |
- Ask Size: - |
Dynavax Technologies... | 16.00 - | 20/09/2024 | Call |
GlobeNewswire
31/08/2020
Dynavax to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference
GlobeNewswire
13/08/2020
Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to Support the Global COVID-19 Respon...
GlobeNewswire
03/08/2020
TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $2...
GlobeNewswire
30/07/2020
Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020
GlobeNewswire
23/07/2020
Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
GlobeNewswire
16/07/2020
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate wi...
GlobeNewswire
14/07/2020
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 ...
GlobeNewswire
10/07/2020
Dynavax and Times Pharmacy Announce Partnership to Offer HEPLISAV-B® Hepatitis B Vaccine to Customer...
GlobeNewswire
19/06/2020
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceut...
GlobeNewswire
09/06/2020
Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodial...
GlobeNewswire
28/05/2020
Dynavax to Present at the William Blair 40th Annual Growth Stock Conference
GlobeNewswire
27/05/2020
Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exe...
GlobeNewswire
22/05/2020
Dynavax Technologies Announces Pricing of $70.0 Million Public Offering of Common Stock
GlobeNewswire
28/04/2020
Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergo...
GlobeNewswire
23/04/2020
Dynavax to Report First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020
GlobeNewswire
16/04/2020
Dynavax and Sinovac Announce Collaboration to Develop a Coronavirus (COVID-19) Vaccine